BioNTech SE ADR buy athque
Start price
13.12.21
/
80%
€239.00
Target price
13.12.22
€230.00
Performance (%)
-30.02%
End price
14.12.22
€167.25
Summary
This prediction ended on 14.12.22 with a price of €167.25. The BUY prediction by athque for BioNTech SE ADR performed very badly with a performance of -30.02%. athque has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioNTech SE ADR | 7.896% | 7.896% | 243.124% |
| iShares Core DAX® | -0.116% | 1.953% | 14.155% |
| iShares Nasdaq 100 | -2.733% | -1.273% | 31.828% |
| iShares Nikkei 225® | -1.721% | 3.263% | 12.922% |
| iShares S&P 500 | -1.527% | 0.194% | 27.117% |
According to athque what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Very positive Cash Flow expected
Top Rating
ROE higher than 15% per year
Small challenges to pay loans and raise capital
Cons
Comments by athque for this prediction
In the thread Biontech SE diskutieren
Kursziel geändert auf 230,0
In the thread Trading Biontech SE
Die von athque gewählte maximale Laufzeit wurde überschritten